IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,307 Cr | ₹2,384 Cr | ₹2,356 Cr | ₹1,806 Cr | ₹1,466 Cr |
What is the latest Total Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,307 Cr |
| Mar2025 | ₹2,384 Cr |
| Mar2024 | ₹2,356 Cr |
| Mar2023 | ₹1,806 Cr |
| Mar2022 | ₹1,466 Cr |
How is Total Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,307 Cr | -3.24 | |
| Mar2025 | ₹2,384 Cr | 1.22 | |
| Mar2024 | ₹2,356 Cr | 30.45 | |
| Mar2023 | ₹1,806 Cr | 23.19 | |
| Mar2022 | ₹1,466 Cr | - | |
Compare Total Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹47,634.7 Cr | 6% | 19.1% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 6% |
19.1% |
25.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses